Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors

Polymyalgia rheumatica (PMR) and PMR-like syndromes are among the most frequent rheumatologic immuno-related adverse events (IRAEs) induced by cancer immunotherapy with “checkpoint inhibitors” (ICIs). Our short communication addresses two key methodological issues laid bare by published literature :...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ciro Manzo, Marco Isetta
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	polymyalgia rheumatica cancer immunotherapy diagnostic and classification criteria adverse drug reactions. Medicine R
Acceso en línea:	https://doaj.org/article/0f269c23c9a44c99b20348f186bd961d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0f269c23c9a44c99b20348f186bd961d
record_format	dspace
spelling	oai:doaj.org-article:0f269c23c9a44c99b20348f186bd961d2021-12-02T18:55:18ZBack to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors0034-62332084-983410.5114/reum.2021.102600https://doaj.org/article/0f269c23c9a44c99b20348f186bd961d2021-02-01T00:00:00Zhttps://www.termedia.pl/Back-to-the-future-identification-and-classification-of-polymyalgia-rheumatica-and-polymyalgia-rheumatica-like-syndromes-following-cancer-immunotherapy-with-checkpoint-inhibitors,18,42980,1,1.htmlhttps://doaj.org/toc/0034-6233https://doaj.org/toc/2084-9834Polymyalgia rheumatica (PMR) and PMR-like syndromes are among the most frequent rheumatologic immuno-related adverse events (IRAEs) induced by cancer immunotherapy with “checkpoint inhibitors” (ICIs). Our short communication addresses two key methodological issues laid bare by published literature : 1) how to diagnose PMR and PMR-like syndromes following ICI therapy, 2) how PMR/PMR-like syndromes following ICI therapy are described as adverse drug reactions (ADRs).Ciro ManzoMarco IsettaTermedia Publishing Housearticlepolymyalgia rheumatica cancer immunotherapy diagnostic and classification criteria adverse drug reactions.MedicineRENRheumatology, Vol 59, Iss 1, Pp 62-63 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	polymyalgia rheumatica cancer immunotherapy diagnostic and classification criteria adverse drug reactions. Medicine R
spellingShingle	polymyalgia rheumatica cancer immunotherapy diagnostic and classification criteria adverse drug reactions. Medicine R Ciro Manzo Marco Isetta Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
description	Polymyalgia rheumatica (PMR) and PMR-like syndromes are among the most frequent rheumatologic immuno-related adverse events (IRAEs) induced by cancer immunotherapy with “checkpoint inhibitors” (ICIs). Our short communication addresses two key methodological issues laid bare by published literature : 1) how to diagnose PMR and PMR-like syndromes following ICI therapy, 2) how PMR/PMR-like syndromes following ICI therapy are described as adverse drug reactions (ADRs).
format	article
author	Ciro Manzo Marco Isetta
author_facet	Ciro Manzo Marco Isetta
author_sort	Ciro Manzo
title	Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
title_short	Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
title_full	Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
title_fullStr	Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
title_full_unstemmed	Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
title_sort	back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
publisher	Termedia Publishing House
publishDate	2021
url	https://doaj.org/article/0f269c23c9a44c99b20348f186bd961d
work_keys_str_mv	AT ciromanzo backtothefutureidentificationandclassificationofpolymyalgiarheumaticaandpolymyalgiarheumaticalikesyndromesfollowingcancerimmunotherapywithcheckpointinhibitors AT marcoisetta backtothefutureidentificationandclassificationofpolymyalgiarheumaticaandpolymyalgiarheumaticalikesyndromesfollowingcancerimmunotherapywithcheckpointinhibitors
_version_	1718377249211678720

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors

Ejemplares similares